• 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
• 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
• 2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis
• 4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients
• A Case of Atypical Scleroderma Renal Crisis
• A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis
• A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale
• A Rare Case of Bullous Morphea Associated with Autoimmune Hepatitis
• ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis
• Acute Kidney Injury in Systemic Sclerosis Beyond Scleroderma Renal Crisis: A Case-Control Study
• An unusual duo: Immunodeficiency disorder and scleroderma
• Approach to interstitial lung disease associated with systemic sclerosis-A survey to pulmonologists and rheumatologists in Colombia
• Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study
• Assessment of fertility and sexual dysfunction in women with systemic sclerosis: a narrative review of the literature
• Can Combination Therapy with Endothelin Receptor Antagonist and PDE5 Inhibitors Prevent Echocardiographic Findings Suspicious for Pulmonary Arterial Hypertension? Description of a Real-Life Case Series
• Can microvascular damage predict disease severity in patients with systemic sclerosis?
• Cannabis therapy in rheumatological diseases: A systematic review
• Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution
• Carpal tunnel syndrome related to rheumatic disease (Review)
• Causal association of basal metabolic rate on systemic sclerosis: a bidirectional mendelian randomization study
• Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)
• Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study
• Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia
• Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease
• Closure of esophageal-pleural fistula using a cardiac occluder in a patient with systemic scleroderma
• Comments on "Investigations of the effects of upper extremity home exercises on grip strength, range of motion, activity performance, and functionality in individuals with systemic sclerosis: a randomized controlled trial"
• Comparison of serum exosome miRNA from patients with Raynaud's phenomenon with positive and negative serum antinuclear antibodies
• Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression
• Corrigendum: Scleroderma and Scleroderma-like syndromes
• Cross-Phenotype GWAS Supports Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis
• Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis
• Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: Scleroderma App for Lesion VErification)
• Do functionality, strength, vascularization, inflammatory and biopsychosocial status improve by biopsychosocial model-based exercise in SSc?
• Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
• Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study
• Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience
• Effector and regulatory B-cell imbalance in systemic sclerosis: cooperation or competition?
• Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog
• Eosinophilic fasciitis: unraveling the clinical tapestry of a rare case and review of literature
• Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study
• ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing-Associated Lymphangiogenesis
• Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study
• Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis
• Exosomal miR-126-3p: Potential protection against vascular damage by regulating the SLC7A5/mTOR Signalling pathway in human umbilical vein endothelial cells
• Exploring the mechanism of luteolin improving immune and inflammatory responses in systemic sclerosis based on systems biology and cell experiments
• Feasibility of a home-based exercise intervention for patients with systemic sclerosis
• Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort
• Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database
• Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis
• Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index
• Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis
• Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions
• New aspects of systemic lupus erythematosus and systemic sclerosis
• Newer Therapies in Rheumatology
• No seasonal trends in referrals for vascular investigations: insight into the diagnosis of Raynaud's phenomenon and systemic sclerosis
• Nodular (keloidal) scleroderma: A case series of 5 patients
• Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up
• Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis
• Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers
• Portuguese Recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases
• Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension
• Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis
• Progranulin, sICAM-1, and sVCAM-1 May Predict an Increased Risk for Ventricular Arrhythmias in Patients with Systemic Sclerosis
• Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases
• PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study
• Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis
• Pyroptosis and its role in autoimmune skin disease
• Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosis
• Racial variability in immune responses only partially explains differential systemic sclerosis disease severity
• Regenerative treatments for scleroderma in cutaneous manifestations of the face: a systematic review
• Role of TGFbeta-producing regulatory T cells in scleroderma and end-stage organ failure
• Scattered pustular lesions 10 days after Shingrix vaccination in systemic sclerosis patient after successful autologous non-myeloablative haemopoietic stem-cell transplantation
• Scleritis in Systemic Sclerosis Treated With Infliximab Biosimilar
• Seasonal fluctuation of serum Krebs von den Lungen-6 levels in systemic sclerosis-associated interstitial lung disease
• Sexual dysfunction among female patients with rheumatic diseases
• Shear wave elastography-derived scoring system: application in the detection, subdivision and evaluation of systemic sclerosis
• Significance of Systemic Scleroderma-Specific Autoantibodies in Idiopathic Interstitial Pneumonia
• Skin Ultrasound Assessment of Patients with Systemic Scleroderma-An Observational Study
• Subclinical right ventricular dysfunction diagnosis in systemic sclerosis
• Systemic sclerosis and environment: an intriguing and still debated association
• Systemic sclerosis and inflammatory myopathy after treatment with durvalumab in a patient with rectal neoplasm
• Systemic Sclerosis With a Normotensive Scleroderma Renal Crisis: A Diagnostic Dilemma
• Systemic Sclerosis With Cardiac Manifestations: A Case Report
• Systemic sclerosis: one year in review 2024
• Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
• Targeting CD13/aminopeptidase N as a novel therapeutic approach for scleroderma fibrosis
• Targeting complement dysregulation: eculizumab in scleroderma renal crisis management-a case-based review
• The burden and determinants of fatigue in incident and prevalent systemic sclerosis
• The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis
• The Potential Effects of Diffuse Scleroderma in a Patient With Cervical Kyphosis
• The usefulness of nailfold capillaroscopy in scleroderma-spectrum disorders: a single-centre observational study
• Therapeutic Promise of Hyaluronidase in Systemic Sclerosis: A Systematic Review
• Therapeutic strategies for primary heart involvement in systemic sclerosis
• Thymic stromal lymphopoietin and digital microvascular damage in systemic sclerosis patients: A pilot study
• Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis
• Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry
• Trace Element Deficiency in Systemic Sclerosis-Too Much Effort for Some Traces?
• Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses
• Unveiling Arrhythmogenic Right Ventricular Cardiomyopathy in Scleroderma
• Update on systemic sclerosis